Rossari Historical Balance Sheet

ROSSARI Stock

831.90 6.45 0.78%

Trend analysis of Rossari Biotech Limited balance sheet accounts such as Total Stockholder Equity of 12.7 B, Other Liab of 1.9 B, Net Tangible Assets of 6.6 B or Property Plant And Equipment Net of 5.1 B provides information on Rossari Biotech's total assets, liabilities, and equity, which is the actual value of Rossari Biotech to its prevalent stockholders. By breaking down trends over time using Rossari Biotech balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Rossari Biotech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Rossari Biotech is a good buy for the upcoming year.

Rossari Biotech Inventory

3.41 Billion

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rossari Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Rossari Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Rossari Biotech at a specified time, usually calculated after every quarter, six months, or one year. Rossari Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Rossari Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Rossari currently owns. An asset can also be divided into two categories, current and non-current.

Rossari Biotech Balance Sheet Chart

As of now, Rossari Biotech's Total Current Liabilities is increasing as compared to previous years. The Rossari Biotech's current Total Stockholder Equity is estimated to increase to about 12.7 B, while Accounts Payable is projected to decrease to under 1.4 B.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Non Currrent Assets Other Non Current Liabilities Total

Add Fundamental

Total Assets

Total assets refers to the total amount of Rossari Biotech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Rossari Biotech books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Rossari Biotech balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Rossari Biotech Limited are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Most accounts from Rossari Biotech's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Rossari Biotech current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rossari Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	739.3M	1.2B	1.4B	1.4B
Total Assets	13.7B	15.7B	18.1B	19.0B

Short Long Term Debt Total Total Assets

Rossari Biotech balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets
Total Assets		0.83	0.93	1.0	1.0	0.97	0.97	1.0	0.54	0.58	0.99	0.91	0.75	1.0	0.59	0.64	0.65	0.86	0.79	0.54	0.93	0.99	0.93	0.91	1.0	1.0
Short Long Term Debt Total	0.83		0.93	0.87	0.83	0.77	0.73	0.82	0.13	0.91	0.87	0.66	0.49	0.8	0.5	0.53	0.51	0.78	0.54	0.47	0.65	0.86	0.95	0.79	0.83	0.85
Other Current Liab	0.93	0.93		0.95	0.93	0.89	0.85	0.92	0.39	0.75	0.95	0.79	0.63	0.91	0.46	0.51	0.54	0.78	0.67	0.45	0.75	0.94	1.0	0.84	0.92	0.93
Total Current Liabilities	1.0	0.87	0.95		0.99	0.96	0.95	0.99	0.48	0.65	1.0	0.89	0.71	0.99	0.58	0.64	0.62	0.87	0.78	0.51	0.9	0.99	0.95	0.91	0.99	1.0
Total Stockholder Equity	1.0	0.83	0.93	0.99		0.97	0.98	1.0	0.54	0.58	0.99	0.91	0.75	0.99	0.59	0.63	0.65	0.85	0.79	0.55	0.92	0.99	0.93	0.9	0.99	1.0
Other Liab	0.97	0.77	0.89	0.96	0.97		0.93	0.97	0.66	0.52	0.94	0.87	0.75	0.99	0.53	0.56	0.56	0.8	0.72	0.4	0.96	0.96	0.89	0.96	0.98	0.96
Net Tangible Assets	0.97	0.73	0.85	0.95	0.98	0.93		0.97	0.57	0.44	0.96	0.93	0.8	0.96	0.67	0.69	0.76	0.8	0.85	0.66	0.91	0.95	0.84	0.82	0.96	0.98
Property Plant And Equipment Net	1.0	0.82	0.92	0.99	1.0	0.97	0.97		0.52	0.59	0.99	0.9	0.7	1.0	0.55	0.61	0.61	0.89	0.79	0.5	0.92	0.99	0.92	0.9	0.99	0.99
Current Deferred Revenue	0.54	0.13	0.39	0.48	0.54	0.66	0.57	0.52		-0.22	0.45	0.52	0.78	0.59	0.33	0.22	0.44	0.15	0.41	0.22	0.7	0.45	0.37	0.59	0.55	0.5
Net Debt	0.58	0.91	0.75	0.65	0.58	0.52	0.44	0.59	-0.22		0.65	0.38	0.08	0.56	0.2	0.27	0.15	0.72	0.26	0.17	0.37	0.66	0.79	0.58	0.59	0.61
Retained Earnings	0.99	0.87	0.95	1.0	0.99	0.94	0.96	0.99	0.45	0.65		0.9	0.69	0.98	0.56	0.62	0.63	0.87	0.79	0.54	0.87	0.99	0.95	0.87	0.98	1.0
Accounts Payable	0.91	0.66	0.79	0.89	0.91	0.87	0.93	0.9	0.52	0.38	0.9		0.76	0.9	0.62	0.73	0.69	0.75	0.88	0.59	0.85	0.88	0.78	0.77	0.9	0.91
Cash	0.75	0.49	0.63	0.71	0.75	0.75	0.8	0.7	0.78	0.08	0.69	0.76		0.75	0.79	0.72	0.88	0.32	0.71	0.74	0.79	0.65	0.6	0.72	0.74	0.74
Non Current Assets Total	1.0	0.8	0.91	0.99	0.99	0.99	0.96	1.0	0.59	0.56	0.98	0.9	0.75		0.56	0.61	0.61	0.85	0.77	0.49	0.94	0.98	0.91	0.92	1.0	0.99
Non Currrent Assets Other	0.59	0.5	0.46	0.58	0.59	0.53	0.67	0.55	0.33	0.2	0.56	0.62	0.79	0.56		0.91	0.9	0.33	0.76	0.88	0.62	0.51	0.46	0.57	0.6	0.62
Other Assets	0.64	0.53	0.51	0.64	0.63	0.56	0.69	0.61	0.22	0.27	0.62	0.73	0.72	0.61	0.91		0.82	0.48	0.78	0.8	0.65	0.58	0.5	0.6	0.65	0.66
Cash And Short Term Investments	0.65	0.51	0.54	0.62	0.65	0.56	0.76	0.61	0.44	0.15	0.63	0.69	0.88	0.61	0.9	0.82		0.31	0.74	0.97	0.61	0.56	0.52	0.51	0.63	0.67
Net Receivables	0.86	0.78	0.78	0.87	0.85	0.8	0.8	0.89	0.15	0.72	0.87	0.75	0.32	0.85	0.33	0.48	0.31		0.64	0.28	0.75	0.91	0.81	0.74	0.86	0.86
Common Stock Shares Outstanding	0.79	0.54	0.67	0.78	0.79	0.72	0.85	0.79	0.41	0.26	0.79	0.88	0.71	0.77	0.76	0.78	0.74	0.64		0.69	0.72	0.77	0.65	0.62	0.78	0.81
Short Term Investments	0.54	0.47	0.45	0.51	0.55	0.4	0.66	0.5	0.22	0.17	0.54	0.59	0.74	0.49	0.88	0.8	0.97	0.28	0.69		0.46	0.46	0.43	0.35	0.51	0.58
Non Current Liabilities Total	0.93	0.65	0.75	0.9	0.92	0.96	0.91	0.92	0.7	0.37	0.87	0.85	0.79	0.94	0.62	0.65	0.61	0.75	0.72	0.46		0.88	0.76	0.94	0.94	0.9
Inventory	0.99	0.86	0.94	0.99	0.99	0.96	0.95	0.99	0.45	0.66	0.99	0.88	0.65	0.98	0.51	0.58	0.56	0.91	0.77	0.46	0.88		0.95	0.89	0.99	0.99
Other Current Assets	0.93	0.95	1.0	0.95	0.93	0.89	0.84	0.92	0.37	0.79	0.95	0.78	0.6	0.91	0.46	0.5	0.52	0.81	0.65	0.43	0.76	0.95		0.86	0.92	0.94
Other Stockholder Equity	0.91	0.79	0.84	0.91	0.9	0.96	0.82	0.9	0.59	0.58	0.87	0.77	0.72	0.92	0.57	0.6	0.51	0.74	0.62	0.35	0.94	0.89	0.86		0.93	0.89
Total Liab	1.0	0.83	0.92	0.99	0.99	0.98	0.96	0.99	0.55	0.59	0.98	0.9	0.74	1.0	0.6	0.65	0.63	0.86	0.78	0.51	0.94	0.99	0.92	0.93		0.99
Total Current Assets	1.0	0.85	0.93	1.0	1.0	0.96	0.98	0.99	0.5	0.61	1.0	0.91	0.74	0.99	0.62	0.66	0.67	0.86	0.81	0.58	0.9	0.99	0.94	0.89	0.99

Click cells to compare fundamentals

Rossari Biotech Account Relationship Matchups

High Positive Relationship

Total Current Liabilities	+ 1.0	Total Assets
Total Stockholder Equity	+ 1.0	Total Assets
Property Plant And Equipment Net	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets

High Negative Relationship

Net Debt

- 0.22

Current Deferred Revenue

Rossari Biotech balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	5.6B	12.6B	13.7B	15.7B	18.1B	19.0B
Other Current Liab	190.7M	157.1M	1.1B	1.3B	1.5B	1.6B
Total Current Liabilities	1.5B	2.9B	3.5B	4.2B	4.9B	5.1B
Total Stockholder Equity	4.1B	8.1B	9.2B	10.5B	12.0B	12.7B
Other Liab	35.6M	21.7M	23.9M	1.6B	1.8B	1.9B
Net Tangible Assets	1.2B	2.8B	4.0B	5.4B	6.3B	6.6B
Property Plant And Equipment Net	1.7B	3.5B	3.3B	4.3B	4.9B	5.1B
Current Deferred Revenue	53.9M	903.5M	1.2B	125.1M	143.9M	261.6M
Net Debt	(152.1M)	(290.5M)	41.0M	936.2M	1.1B	1.1B
Retained Earnings	2.4B	3.3B	4.4B	5.6B	6.5B	6.8B
Accounts Payable	1.3B	1.9B	1.8B	2.2B	2.5B	1.4B
Cash	152.1M	374.8M	698.3M	251.7M	289.5M	254.9M
Non Current Assets Total	2.1B	6.5B	6.5B	7.3B	8.4B	8.8B
Non Currrent Assets Other	55.9M	130.5M	183.4M	104.4M	120.0M	122.5M
Other Assets	130.3M	255.6M	58.9M	144.0M	165.6M	114.4M
Cash And Short Term Investments	883.6M	644.3M	1.5B	667.9M	768.0M	732.6M
Net Receivables	1.5B	3.0B	(23.4M)	4.3B	4.9B	5.1B
Common Stock Shares Outstanding	51.9M	55.2M	55.4M	55.3M	63.6M	53.1M
Short Term Investments	731.5M	269.5M	819.5M	416.2M	478.6M	477.7M
Liabilities And Stockholders Equity	5.6B	12.6B	13.7B	15.7B	18.1B	19.0B
Non Current Liabilities Total	23.9M	1.6B	1.1B	996.9M	1.1B	1.2B
Inventory	953.5M	1.9B	1.9B	2.8B	3.2B	3.4B
Other Current Assets	242.2M	500.8M	3.8B	4.9B	5.7B	6.0B
Other Stockholder Equity	(2.5B)	4.6B	4.6B	4.7B	5.4B	5.7B
Total Liab	1.5B	4.5B	4.5B	5.2B	6.0B	6.3B
Total Current Assets	3.5B	6.1B	7.2B	8.4B	9.7B	10.2B
Short Term Debt	53.9M	(714.9M)	390.0M	745.6M	857.5M	900.3M
Intangible Assets	107.6M	1.7B	1.5B	1.4B	1.7B	1.7B
Common Stock	103.9M	110.1M	110.3M	110.5M	127.1M	91.9M
Property Plant Equipment	708.6M	1.1B	1.7B	3.5B	4.0B	4.2B
Net Invested Capital	4.1B	8.1B	9.9B	11.5B	13.3B	13.9B
Short Long Term Debt	0.0	84.3M	390.0M	725.0M	833.8M	875.5M
Net Working Capital	2.0B	3.1B	3.7B	4.2B	4.8B	2.5B
Capital Stock	103.9M	110.1M	110.3M	110.5M	127.1M	106.4M
Property Plant And Equipment Gross	2.2B	4.3B	3.3B	3.6B	4.2B	3.2B
Accumulated Other Comprehensive Income	21.2M	32.9M	35.0M	35.4M	40.7M	28.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

Other Information on Investing in Rossari Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Rossari Historical Balance Sheet

Rossari Biotech Inventory

3.41 Billion

About Rossari Balance Sheet Analysis

Rossari Biotech Balance Sheet Chart

Total Assets

Total Current Liabilities

Non Currrent Assets Other

Rossari Biotech balance sheet Correlations

Rossari Biotech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Rossari Biotech balance sheet Accounts

Also Currently Popular

Other Information on Investing in Rossari Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY